Retatrutide appears to be a new treatment in the fight against obesity. This revolutionary drug, categorized as a dual GLP-1 and GIP receptor agonist, shows promising results in clinical trials. By stimulating these receptors, Retatrutide reduces hunger pangs, {promotesenergy expenditure, and ultimately results in significant slimming. While studi